AU2010347212B2 - Cell free preparation and uses thereof - Google Patents

Cell free preparation and uses thereof

Info

Publication number
AU2010347212B2
AU2010347212B2 AU2010347212A AU2010347212A AU2010347212B2 AU 2010347212 B2 AU2010347212 B2 AU 2010347212B2 AU 2010347212 A AU2010347212 A AU 2010347212A AU 2010347212 A AU2010347212 A AU 2010347212A AU 2010347212 B2 AU2010347212 B2 AU 2010347212B2
Authority
AU
Australia
Prior art keywords
cell free
free preparation
preparation
tendon
population
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010347212A
Other versions
AU2010347212A1 (en
Inventor
Graham Vesey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cell Ideas Pty Ltd
Original Assignee
Cell Ideas Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Ideas Pty Ltd filed Critical Cell Ideas Pty Ltd
Priority to AU2010347212A priority Critical patent/AU2010347212B2/en
Publication of AU2010347212A1 publication Critical patent/AU2010347212A1/en
Application granted granted Critical
Publication of AU2010347212B2 publication Critical patent/AU2010347212B2/en
Priority to AU2016244319A priority patent/AU2016244319B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

CELL FREE PREPARATION AND USES THEREOF Provided herein is a method for treating a joint, tendon or ligament injury by locally administering a cell free composition generated by exposure of a medium to a population of cells. Also provided is use of cell free composition generated by exposure of a medium to a population of cells for the preparation of a medicament for treatment of a joint, tendon or ligament injury. 2962318-1
AU2010347212A 2010-09-14 2010-09-14 Cell free preparation and uses thereof Ceased AU2010347212B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2010347212A AU2010347212B2 (en) 2010-09-14 2010-09-14 Cell free preparation and uses thereof
AU2016244319A AU2016244319B2 (en) 2010-09-14 2016-10-14 Cell free preparation and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2010347212A AU2010347212B2 (en) 2010-09-14 2010-09-14 Cell free preparation and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2016244319A Division AU2016244319B2 (en) 2010-09-14 2016-10-14 Cell free preparation and uses thereof

Publications (2)

Publication Number Publication Date
AU2010347212A1 AU2010347212A1 (en) 2012-03-29
AU2010347212B2 true AU2010347212B2 (en) 2016-07-14

Family

ID=45908092

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2010347212A Ceased AU2010347212B2 (en) 2010-09-14 2010-09-14 Cell free preparation and uses thereof
AU2016244319A Ceased AU2016244319B2 (en) 2010-09-14 2016-10-14 Cell free preparation and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2016244319A Ceased AU2016244319B2 (en) 2010-09-14 2016-10-14 Cell free preparation and uses thereof

Country Status (1)

Country Link
AU (2) AU2010347212B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016094932A1 (en) 2014-12-19 2016-06-23 Cell Ideas Pty Ltd Improved cell therapies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2585740A1 (en) * 2004-10-28 2006-05-11 Medivas, Llc Bioactive wound dressings and implantable devices and methods of use
AU2009201915C1 (en) * 2008-08-22 2015-02-26 Regeneus Ltd Therapeutic methods

Also Published As

Publication number Publication date
AU2010347212A1 (en) 2012-03-29
AU2016244319B2 (en) 2018-05-17
AU2016244319A1 (en) 2016-11-03

Similar Documents

Publication Publication Date Title
PE20150223A1 (en) ANTIBODIES ENHANCED ANTIBODIES AGAINST GROWTH AND DIFFERENTIATION FACTOR-8 AND THE USES OF THEM
EP3587558A3 (en) Methods of populating a gastrointestinal tract
CR11723A (en) AGENT TO TREAT DISEASE
EA201201648A1 (en) SGC STIMULATORS
NZ609201A (en) Means and methods for treating dlbcl
TN2011000437A1 (en) Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
AU2011328009A8 (en) Compounds and methods for treating pain
IN2015DN02729A (en)
EA201290859A1 (en) TREATMENT OF LUPUS-ARTHRITIS USING LAQUINIMODE
MX2010002392A (en) Improved brimonidine compositions for treating erythema.
WO2009151907A3 (en) Compositions and methods for using cells to treat heart tissue
EP4327886A3 (en) Pyrimido- pyridazinone compounds and use thereof
NZ607306A (en) Compounds and methods for skin repair
MX2010004857A (en) Benzodiazepinone compounds useful in the treatment of skin conditions.
BR112013020586A2 (en) USE OF UMBILICAL CORD TISSUE DERIVED CELLS
MX2011006006A (en) Compounds, pharmaceutical composition and methods for use in treating metabolic disorders.
GEP20196969B (en) New therapeutical composition containing apomorphine as active ingredient
MX367131B (en) 3,6-disubstituted xanthylium salts as medicaments.
WO2010097788A3 (en) Visfatin therapeutic agents for the treatment of acne and other conditions
EA201001749A1 (en) METHOD OF TREATMENT OF DIFFERENTIATED ARTHRITIS
MX2014000567A (en) Treatment of radiation injury using amnion derived adherent cells.
WO2011044523A3 (en) Compositions and methods for treating obesity
WO2009069355A1 (en) Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell
SG195170A1 (en) Methods of treating or preventing rheumatic disease
WO2011091154A3 (en) Use of human erythrocytes for prevention and treatment of cancer dissemination and growth

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired